136 related articles for article (PubMed ID: 38606839)
1. Surgical outcomes for non-small cell lung cancer in younger adults: A population-based study.
Zhang Z; Huo H; Li F; Miao J; Hu B; Chen S
Thorac Cancer; 2024 May; 15(15):1218-1227. PubMed ID: 38606839
[TBL] [Abstract][Full Text] [Related]
2. Thermal ablation matches sublobar resection outcomes in older patients with early-stage non-small cell lung cancer.
Kwan SW; Mortell KE; Talenfeld AD; Brunner MC
J Vasc Interv Radiol; 2014 Jan; 25(1):1-9.e1. PubMed ID: 24365502
[TBL] [Abstract][Full Text] [Related]
3. Treatment of clinical T4 stage superior sulcus non-small cell lung cancer: a propensity-matched analysis of the surveillance, epidemiology, and end results database.
Wen J; Liu D; Chen D; Chen J; Xu X; Chen C; Zhang F; Duan S; Zhu R; Fan M; Chen Y
Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30647107
[No Abstract] [Full Text] [Related]
4. Surgical choice for patients with stage I non-small-cell lung cancer ≤2 cm: an analysis from surveillance, epidemiology, and end results database.
Wu L; Zhao W; Chen T; Yang Y
J Cardiothorac Surg; 2021 Jul; 16(1):191. PubMed ID: 34233699
[TBL] [Abstract][Full Text] [Related]
5. Impact of preoperative radiation on survival of patients with T3N0 >7-cm non-small cell lung cancers treated with anatomic resection using the Surveillance, Epidemiology, and End Results database.
Moreno AC; Morgensztern D; Yu JB; Boffa DJ; Decker RH; Detterbeck FC; Kim AW
J Surg Res; 2013 Sep; 184(1):10-8. PubMed ID: 23583079
[TBL] [Abstract][Full Text] [Related]
6. The prognosis after contraindicated surgery of NSCLC patients with malignant pleural effusion (M1a) may be better than expected.
Ren Y; Dai C; Shen J; Liu Y; Xie D; Zheng H; He J; Liang W; Jiang G; Fei K; Yang P; He J; Chen C
Oncotarget; 2016 May; 7(18):26856-65. PubMed ID: 27057627
[TBL] [Abstract][Full Text] [Related]
7. Choice of postoperative radiation for stage IIIA pathologic N2 non-small cell lung cancer: impact of metastatic lymph node number.
Wang S; Ma Z; Yang X; Wang Y; Xu Y; Xia W; Chen R; Qiu M; Jiang F; Yin R; Xu L; Xu K
Radiat Oncol; 2017 Dec; 12(1):207. PubMed ID: 29284511
[TBL] [Abstract][Full Text] [Related]
8. The impact of order with radiation therapy in stage IIIA pathologic N2 NSCLC patients: a population-based study.
Duan H; Liang L; Xie S; Wang C
BMC Cancer; 2020 Aug; 20(1):809. PubMed ID: 32847544
[TBL] [Abstract][Full Text] [Related]
9. Survival benefit of thermal ablation combined with chemotherapy for the treatment of stage IV nonsmall cell lung cancer: a propensity-matched analysis.
Yang H; Li M; Mei T
Int J Hyperthermia; 2022; 39(1):348-357. PubMed ID: 35164638
[TBL] [Abstract][Full Text] [Related]
10. Choice of Surgical Procedure for Patients With Non-Small-Cell Lung Cancer ≤ 1 cm or > 1 to 2 cm Among Lobectomy, Segmentectomy, and Wedge Resection: A Population-Based Study.
Dai C; Shen J; Ren Y; Zhong S; Zheng H; He J; Xie D; Fei K; Liang W; Jiang G; Yang P; Petersen RH; Ng CS; Liu CC; Rocco G; Brunelli A; Shen Y; Chen C; He J
J Clin Oncol; 2016 Sep; 34(26):3175-82. PubMed ID: 27382092
[TBL] [Abstract][Full Text] [Related]
11. Survival Rates After Lobectomy, Segmentectomy, and Wedge Resection for Non-Small Cell Lung Cancer.
Cao J; Yuan P; Wang Y; Xu J; Yuan X; Wang Z; Lv W; Hu J
Ann Thorac Surg; 2018 May; 105(5):1483-1491. PubMed ID: 29462591
[TBL] [Abstract][Full Text] [Related]
12. Segmentectomy versus lobectomy in early non-small cell lung cancer of 2 cm or less in size: A population-based study.
Moon MH; Moon YK; Moon SW
Respirology; 2018 Jul; 23(7):695-703. PubMed ID: 29465766
[TBL] [Abstract][Full Text] [Related]
13. Lobectomy versus segmentectomy in patients with stage T (> 2 cm and ≤ 3 cm) N0M0 non-small cell lung cancer: a propensity score matching study.
Wang L; Ge L; You S; Liu Y; Ren Y
J Cardiothorac Surg; 2022 May; 17(1):110. PubMed ID: 35545793
[TBL] [Abstract][Full Text] [Related]
14. Sublobar resection versus lobectomy in patients aged ≤35 years with stage IA non-small cell lung cancer: a SEER database analysis.
Gu C; Wang R; Pan X; Huang Q; Zhang Y; Yang J; Shi J
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2375-2382. PubMed ID: 28819775
[TBL] [Abstract][Full Text] [Related]
15. Propensity score-matching analysis of postoperative radiotherapy for stage IIIA-N2 non-small cell lung cancer using the Surveillance, Epidemiology, and End Results database.
Wei S; Xie M; Tian J; Song X; Wu B; Liu L
Radiat Oncol; 2017 Jun; 12(1):96. PubMed ID: 28610591
[TBL] [Abstract][Full Text] [Related]
16. Different prognostic significance of examined lymph node count for patients with non-small-cell lung cancer ≤1 cm or >1-2 cm: a population-based study.
Liang Z; Wang X; Yang H; Fu H; Li M; Feng Z; Peng Z; Wang H
Future Oncol; 2020 Jan; 16(3):4497-4509. PubMed ID: 31845824
[No Abstract] [Full Text] [Related]
17. Survival improvements for advanced stage nonbronchioloalveolar carcinoma-type nonsmall cell lung cancer cases with ipsilateral intrapulmonary nodules.
Zell JA; Ou SH; Ziogas A; Anton-Culver H
Cancer; 2008 Jan; 112(1):136-43. PubMed ID: 17960795
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of age at diagnosis among young non-small cell lung cancer patients under 40 years old: a population-based study.
Liu M; Cai X; Yu W; Lv C; Fu X
Oncotarget; 2015 Dec; 6(42):44963-70. PubMed ID: 26517681
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of local thoracic surgery in patients with stage IV non-small-cell lung cancer: A SEER-based analysis.
Jia J; Guo B; Yang Z; Liu Y; Ga L; Xing G; Zhang S; Jin A; Ma R; Wang J
Eur J Cancer; 2021 Feb; 144():326-340. PubMed ID: 33388490
[TBL] [Abstract][Full Text] [Related]
20. Propensity score matched analysis for the role of surgery in stage Ⅲ small cell lung cancer based on the eighth edition of the TNM classification: a population study of the US SEER database and a Chinese hospital.
Gao L; Shen L; Wang K; Lu S
Lung Cancer; 2021 Dec; 162():54-60. PubMed ID: 34739854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
